Navigation Links
CareFusion Moves First Quarter Earnings Announcement to November 5
Date:11/3/2009

SAN DIEGO, Nov. 3 /PRNewswire-FirstCall/ -- CareFusion Corporation (NYSE: CFN), a leading, global medical device company created on Sep. 1, 2009 through the spinoff of Cardinal Health's clinical and medical products businesses, today said it will release its first quarter results and host a conference call on Thurs., Nov. 5, 2009 at 8:30 a.m. EST, earlier than the previously announced earnings date.

The company is changing the date of its earnings announcement to coincide with Cardinal Health's first quarter earnings release. CareFusion was part of Cardinal Health for two months of the quarter, and Cardinal Health will present CareFusion results as part of its first quarter discontinued operations. By moving up the earnings release date, the company is seeking to avoid any potential confusion as a result of Cardinal Health's partial presentation of CareFusion results in its discontinued operations, which will differ from the company's reported results.

The CareFusion earnings webcast and conference call will now take place on Nov. 5, 2009 at 8:30 a.m. EST to discuss results for its first quarter of fiscal 2010, ended on Sep. 30, 2009. To access the call and corresponding slide presentation, visit www.carefusion.com on the Investor Relations section under "Calendar of Events," or dial 800-510-9836 or 617-614-3670, passcode 54900921. Log on at least 15 minutes before the call begins to register and download or install any necessary audio software.

A replay of the conference call will be available at 11 a.m. EST on Nov. 5, 2009 through 11:59 p.m. EST on Nov. 7, 2009 and can be accessed by dialing 888-286-8010 or 617-801-6888, passcode 54800850.

CareFusion previously planned to announce on Nov. 10, 2009 at 5 p.m. EST.

About CareFusion Corporation
'/>"/>

SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CareFusion Shipping Ventilators to CDC for National Emergency Preparedness
2. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
3. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
4. GHX Health ConneXion(TM) Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption
5. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
6. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
7. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
8. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
9. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
10. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
11. Corgenix to Host Conference Call to Discuss Fiscal 2010 First Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq...tedtodiscovering,developingandcommercializingnovel...tsforthefiscalyearendedSeptember30,2009.AtSeptembe...alentsandshortterminvestments. ,, PipelineUpda...bTrial ,, InlateNovember2009,anindependentDat...
(Date:11/25/2009)...PRNewswire/--BioTrendsResearchGroup,Inc.releasedWa...firstinamulti-phasesyndicatedmarketresearchproject...fromproductlaunchthroughthefirstsixmonthsofavailab...mationfrom75uniqueDermatologistsandqualitativeinfo...ofStelara,obstaclestouse,typicalpatienttypes,produ...
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--RemediumTechnologies...topsseverebleeding,wonfirstprizeand$10,000intheMos...hallenge2009,companyofficialsannouncetoday. ,, ...emedium,steampitchedtheirinventionattheGSCSecurity..., Remedium( www.remediumtechnologies.com )isdev...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Stop Smoking Vaccine in the Works 59295 1Stop Smoking Vaccine in the Works 59295 2Gary C Baker Named KePRO Chief Financial Officer 59292 1Gary C Baker Named KePRO Chief Financial Officer 59292 2Gary C Baker Named KePRO Chief Financial Officer 59292 3Cosmetic Bootcamp University New York Deemed A Huge Success 59289 1
...est study to examine,the effect of depression on H...orsens a patient,s adherence to highly active anti... effective antidepressant medication,can reverse t...rmanente,Division of Research and the Group Health... of the Journal of Acquired Immune Deficiency Synd...
...Therapies, Inc. (ITI),today announced it has initi...inical study using its drug candidate ITI-722. ITI...ptor antagonist and represents an important new,ap...el separation of 5-HT2A,and dopamine receptor modu...ed not only to treat SMI but it may be highly appr...
Other Medicine Technology:Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment 2Kaiser Permanente - Group Health Study Shows Depression Worsens HIV Treatment 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 2Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 4
(Date:11/26/2009)...nis & Ennis, P.A. is offering free nationwide ...smin birth control pills who have suffered a Deep ... Heart Attack or other related cardiac issues or h...free at 1-800-856-6405 or go to the firm’s w...n online case evaluation form. , ...
(Date:11/25/2009)...5/PRNewswire/--TheBartleHallConventionCenterwillte...c.9-10,whenKansasCityhoststhelatestinaseriesofmass...liniceventhasthepotentialtobethebiggestoneyet,beca...donweekdaysinsteadofoveraweekend,"SheriWood,execut...dentoftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...v.25/PRNewswire/-SentinelleMedicalInc.,aleadingman...ftwareandCalgaryScientificInc.,aleadingproviderofs...ionofAegis(TM)Breast4DAdvancedVisualizationsoftwar...o-footprintWebclientbasedmedicalimagingofferingint...owsforzero-footprintaccess-requiringnosoftwaredown...
(Date:11/25/2009)....25/PRNewswire/--Thanksgivingmealswillbedeliveredt...gBeachareathankstoFaithInAction/VolunteerActionfor...ivisionofSCANHealthPlan.Formorethan17yearstheseorg...rwarmThanksgivingmealstoseniorsinneedinLongBeach,L...oundingcities. ,, "Ourwarmholidaymealsaredelive...
(Date:11/25/2009)...Newswire-USNewswire/--TheBlackAIDSInstituterecentl...eadershipfor2010. ,, ThenewBoardMembersareahigh...cy,law,finance,governmenthealthprograms,editorial,...widerangeofpersonalbackgroundsincludingbothheteros...elves,andrepresentingmultipleagegroups. ,, (Pho...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...er 30, 2008,viewers tuning in to the new CBS dayti...m ) will find hope for stuttering. That day, the,D...er, M.A., CCC-SP,founder of Power Stuttering Cente...recognized stuttering specialist, overcame his own...
... outcomes, but offers no concrete answers , ...mericans who live in low-income ZIP codes are more...n higher-income ZIP codes, according to new resear...99 and 2003. , The risk of death was between 17 p...
...,Inc. (Nasdaq: HRLY ) announced today that its He..., has a contract totaling approximately $1.3 milli..., NY, for the manufacture of,complex switch filter... new,primary maritime-dominance helicopter, replac...
...l-service,provider of public relations, investor r...trategy to life science clients, today announced t...y of record by cancer therapeutics,company, Neotro...company,s,clinical development. Neuroendocrine can...
...ent Specialists signs agreement with PureWellness .... , Burlington, VT (PRWEB...g provider of online wellness solutions, announced... living communities across the country. , , ,&quo...
...tanford University School of ,Medicine have found ...ivity of individual proteins in cells and living m...for identifying more precisely than ever ,before ...e selectively delivered to tumors. , The procedur...
Other Medicine News:Health News:Help for Stutterers on 'The Doctors' TV Show Presented by Power Stuttering Center Founder Mark Power 2Health News:Seniors in Poor Areas More Likely to Die After Surgery 2Health News:Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter 2Health News:LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster 2Health News:Nation's Leading Food Services Provider Chooses PureWellness to Drive Corporate Wellness Program 2Health News:New way to control protein activity could lead to cancer therapies 2Health News:New way to control protein activity could lead to cancer therapies 3
Schuknecht-Weitlaner Retractor
Blunt Weitlaner Retractor
Weitlaner Beckmann Retractor
Baby Weitlaner Retractor
Medicine Products: